State of Alaska Department of Revenue Sells 1,589 Shares of HCA Healthcare Inc (HCA)

State of Alaska Department of Revenue lessened its position in HCA Healthcare Inc (NYSE:HCA) by 3.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,111 shares of the company’s stock after selling 1,589 shares during the period. State of Alaska Department of Revenue’s holdings in HCA Healthcare were worth $6,135,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. FMR LLC increased its stake in shares of HCA Healthcare by 54.9% in the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock valued at $563,097,000 after buying an additional 1,944,961 shares during the period. Renaissance Technologies LLC increased its stake in shares of HCA Healthcare by 187.9% in the second quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock valued at $112,289,000 after buying an additional 714,331 shares during the period. LSV Asset Management increased its stake in shares of HCA Healthcare by 9.2% in the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock valued at $560,133,000 after buying an additional 457,752 shares during the period. Millennium Management LLC increased its stake in shares of HCA Healthcare by 32.3% in the second quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock valued at $174,270,000 after buying an additional 414,877 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of HCA Healthcare by 62.6% in the second quarter. Massachusetts Financial Services Co. MA now owns 891,489 shares of the company’s stock valued at $91,466,000 after buying an additional 343,121 shares during the period. 70.40% of the stock is owned by institutional investors and hedge funds.

Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. increased their price target on HCA Healthcare to $151.00 and gave the company an “overweight” rating in a research note on Monday, July 30th. SunTrust Banks increased their price target on HCA Healthcare to $150.00 and gave the company a “positive” rating in a research note on Tuesday, September 4th. Mizuho reissued a “buy” rating and issued a $145.00 price target on shares of HCA Healthcare in a research note on Thursday, August 2nd. Leerink Swann increased their price target on HCA Healthcare from $125.00 to $140.00 and gave the company an “outperform” rating in a research note on Thursday, July 26th. Finally, Argus increased their price target on HCA Healthcare to $150.00 and gave the company a “buy” rating in a research note on Friday, September 7th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $135.19.

Shares of HCA Healthcare stock opened at $133.86 on Friday. HCA Healthcare Inc has a one year low of $71.18 and a one year high of $141.11. The company has a debt-to-equity ratio of -7.64, a quick ratio of 1.15 and a current ratio of 1.36. The stock has a market cap of $48.14 billion, a P/E ratio of 20.31, a price-to-earnings-growth ratio of 1.23 and a beta of 0.49.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, beating the consensus estimate of $2.16 by $0.13. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The company had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. During the same quarter in the prior year, the company earned $1.73 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. Equities research analysts expect that HCA Healthcare Inc will post 9.23 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 28th. Investors of record on Tuesday, September 4th were given a dividend of $0.35 per share. The ex-dividend date was Friday, August 31st. This represents a $1.40 annualized dividend and a dividend yield of 1.05%. HCA Healthcare’s payout ratio is 21.24%.

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,689 shares of the stock in a transaction that occurred on Wednesday, July 25th. The stock was sold at an average price of $112.53, for a total value of $190,063.17. Following the transaction, the senior vice president now owns 10,057 shares in the company, valued at $1,131,714.21. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 1,530 shares of the stock in a transaction that occurred on Friday, July 27th. The stock was sold at an average price of $124.47, for a total value of $190,439.10. Following the completion of the transaction, the senior vice president now owns 9,307 shares in the company, valued at approximately $1,158,442.29. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 170,257 shares of company stock worth $21,118,053. 2.80% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Growth Stocks, What They Are, What They Are Not

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply